Equillium, Inc.
EQ
$1.47
-$0.02-1.34%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/9/2025
-
MarketBeat
10/6/2025
-
GuruFocus
10/6/2025
-
GuruFocus
10/6/2025
-
The Fly
10/6/2025
-
Globe Newswire
9/24/2025
-
MarketBeat
9/23/2025
-
Globe Newswire
9/17/2025
-
MarketBeat
9/9/2025
-
TipRanks Financial Blog
9/9/2025
-
The Fly
9/6/2025
-
Ticker Report
9/4/2025
-
MarketBeat
9/4/2025
-
Ticker Report
9/3/2025
-
GuruFocus
9/3/2025
-
Business Wire
8/29/2025
-
GuruFocus
8/29/2025
-
GuruFocus
8/29/2025
-
Business Wire
8/28/2025
-
SeekingAlpha
8/20/2025
-
The Fly
8/12/2025
-
TipRanks Financial Blog
8/12/2025
-
TipRanks Financial Blog
8/11/2025
-
GuruFocus
8/11/2025
-
Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 14, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 240 1200
Address
2223 Avenida De La Playa
La Jolla, CA 92037
La Jolla, CA 92037
Country
Year Founded
Business Description
Sector
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United...
more